Meropenem NDC 72078-081

NDC codes

FDA NDC Directory

Product NDC (as listed)72078-081Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72078-0081Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72078-081-06	72078008106	6 INJECTION in 1 CARTON (72078-081-06)Marketed from Jul 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meropenem
Generic name (nonproprietary): meropenem
Active ingredients: Meropenem anhydrous — 2 g/1
Dosage form: Injection
Route: Intravenous
Labeler: Mylan Institutional LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219084
Marketing start: Jul 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Carbapenems (Chemical structure)
Identifiers: Product ID 72078-081_3ac13eb5-b99e-87cf-e063-6394a90adb59SPL ID 3ac13eb5-b99e-87cf-e063-6394a90adb59SPL set ID f5154b6f-bca8-4f1e-907b-48ea34caf483RxCUI 2664894UNII YOP6PX0BAO
Pharmacologic class: Penem Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472078008106 followed by a unit qualifier and the quantity

Package 72078-0081-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 25, 2024.

Indications (excerpt from the label)

1.1 Bacterial Meningitis (Pediatric Patients 3 Months of Age and Older Only) Meropenem for Injection is indicated for the treatment of bacterial meningitis caused by Haemophilus influenzae, Neisseria meningitidis and penicillin-susceptible isolates of Streptococcus pneumoniae , in pediatric patients 3 months of age and older. Meropenem for injection has been found to be effective in eliminating concurrent bacteremia in association with bacterial meningitis. 1.2 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection and other antibacterial drugs, Meropenem for Injection should only be used to treat or prevent infections that are pr…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219084

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219084
Product	Strength	Form · route	Labeler	Product NDC
Meropenem	Meropenem anhydrous 2 g/1	InjectionIntravenous	BROOKS STERISCIENCE LIMITED	81962-002